Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    AbbVie Inc.

    NYSE: ABBV · Real-Time Price · USD
    190.70
    -0.38 (-0.20%)
    At close: Jun 16, 2025, 3:59 PM
    189.82
    -0.46%
    After-hours: Jun 16, 2025, 07:09 PM EDT

    AbbVie Statistics

    Share Statistics

    AbbVie has 1.77B shares outstanding. The number of shares has increased by 0.18% in one year.

    Shares Outstanding

    n/a
    		 1.77B

    Shares Change (YoY)

    n/a
    		 0.18%

    Shares Change (QoQ)

    n/a
    		 0.1%

    Owned by Institutions (%)

    n/a
    		 71.97%

    Shares Floating

    n/a
    		 1.76B

    Failed to Deliver (FTD) Shares

    n/a
    		 1,237

    FTD / Avg. Volume

    n/a
    		 0.02%

    Short Selling Information

    The latest short interest is 15.89M, so 0.9% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 15.89M

    Short % of Shares Out

    n/a
    		 0.9%

    Short % of Float

    n/a
    		 0.9%

    Short Ratio (days to cover)

    n/a
    		 2.75

    Valuation Ratios

    The PE ratio is 73.48 and the forward PE ratio is 13.73. AbbVie's PEG ratio is -6.08.

    PE Ratio

    n/a
    		 73.48

    Forward PE

    n/a
    		 13.73

    PS Ratio

    n/a
    		 5.58

    Forward PS

    n/a
    		 4.4

    PB Ratio

    n/a
    		 94.54

    P/FCF Ratio

    n/a
    		 17.63

    PEG Ratio

    n/a
    		 -6.08
    Financial Ratio History

    Enterprise Valuation

    AbbVie has an Enterprise Value (EV) of 375.97B.

    EV / Sales

    n/a
    		 6.67

    EV / EBITDA

    n/a
    		 25.22

    EV / EBIT

    n/a
    		 19.99

    EV / FCF

    n/a
    		 21.08

    Financial Position

    The company has a current ratio of 0.66, with a Debt / Equity ratio of 20.19.

    Current Ratio

    n/a
    		 0.66

    Quick Ratio

    n/a
    		 0.55

    Debt / Equity

    n/a
    		 20.19

    Debt / EBITDA

    n/a
    		 4.5

    Debt / FCF

    n/a
    		 3.77

    Interest Coverage

    n/a
    		 5.92

    Financial Efficiency

    Return on Equity is 128.66% and Return on Invested Capital is 18.58%.

    Return on Equity

    n/a
    		 128.66%

    Return on Assets

    n/a
    		 3.17%

    Return on Invested Capital

    n/a
    		 18.58%

    Revenue Per Employee

    n/a
    		 $1,024,254.55

    Profits Per Employee

    n/a
    		 $77,781.82

    Employee Count

    n/a
    		 55,000

    Asset Turnover

    n/a
    		 0.42

    Inventory Turnover

    n/a
    		 4.04

    Taxes

    Income Tax

    n/a
    		 -570M

    Effective Tax Rate

    n/a
    		 -15.34%

    Stock Price Statistics

    The stock price has increased by 13.25% in the last 52 weeks. The beta is 0.49, so AbbVie's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.49

    52-Week Price Change

    n/a
    		 13.25%

    50-Day Moving Average

    n/a
    		 185.09

    200-Day Moving Average

    n/a
    		 188.86

    Relative Strength Index (RSI)

    n/a
    		 56.84

    Average Volume (20 Days)

    n/a
    		 7,713,680

    Income Statement

    In the last 12 months, AbbVie had revenue of 56.33B and earned 4.28B in profits. Earnings per share was 2.4.

    Revenue

    n/a
    		 56.33B

    Gross Profit

    n/a
    		 39.43B

    Operating Income

    n/a
    		 16.63B

    Net Income

    n/a
    		 4.28B

    EBITDA

    n/a
    		 14.91B

    EBIT

    n/a
    		 6.52B

    Earnings Per Share (EPS)

    n/a
    		 2.4
    Full Income Statement

    Balance Sheet

    The company has 5.52B in cash and 67.14B in debt, giving a net cash position of -61.62B.

    Cash & Cash Equivalents

    n/a
    		 5.52B

    Total Debt

    n/a
    		 67.14B

    Net Cash

    n/a
    		 -61.62B

    Retained Earnings

    n/a
    		 -7.9B

    Total Assets

    n/a
    		 136.16B

    Working Capital

    n/a
    		 -8.73B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 18.81B and capital expenditures -974M, giving a free cash flow of 17.83B.

    Operating Cash Flow

    n/a
    		 18.81B

    Capital Expenditures

    n/a
    		 -974M

    Free Cash Flow

    n/a
    		 17.83B

    FCF Per Share

    n/a
    		 10.08
    Full Cash Flow Statement

    Margins

    Gross margin is 69.99%, with operating and profit margins of 29.51% and 7.59%.

    Gross Margin

    n/a
    		 69.99%

    Operating Margin

    n/a
    		 29.51%

    Pretax Margin

    n/a
    		 6.6%

    Profit Margin

    n/a
    		 7.59%

    EBITDA Margin

    n/a
    		 26.47%

    EBIT Margin

    n/a
    		 29.51%

    FCF Margin

    n/a
    		 31.65%

    Dividends & Yields

    ABBV pays an annual dividend of $7.93, which amounts to a dividend yield of 3.61%.

    Dividend Per Share

    n/a
    		 $7.93

    Dividend Yield

    n/a
    		 3.61%

    Dividend Growth (YoY)

    n/a
    		 5.81%

    Payout Ratio

    n/a
    		 336.02%

    Earnings Yield

    n/a
    		 1.36%

    FCF Yield

    n/a
    		 5.67%
    Dividend Details

    Analyst Forecast

    The average price target for ABBV is $211, which is 10.5% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $211

    Price Target Difference

    n/a
    		 10.5%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 20
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $12

    Lynch Upside

    n/a
    		 -93.71%

    Graham Number

    n/a
    		 10.11

    Graham Upside

    n/a
    		 -94.7%

    Scores

    Altman Z-Score

    n/a
    		 1.88

    Piotroski F-Score

    n/a
    		 7

    Add to Watchlist